Author: Bella Hayes
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IAS Source link
APLT DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action – APLT Source link
ROSEN, A LEADING LAW FIRM, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBA Source link
Rinnai Praises President Trump and New US Energy Secretary Wright's Decision to Reverse Biden Era Rule That Would Have Banned One of its Most Popular Products Source link
Currency Exchange International, Corp. Announces Strategic Decision to Discontinue Operations of its Subsidiary, Exchange Bank of Canada, Pursue Referral Agreements with Appropriate Parties, and Seek Source link
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ™DX Source link
Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus N Source link
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN Source link
KSPI DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action First Filed by Source link
UPDATE – Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings Source link
